
Spine
Ropivacaine Epidural Injection Effective in Posterior Lumbar Interbody Spinal Arthrodesis
This report has been verified
by one or more authors of the
original publication.
J Bone Joint Surg Am. 2013 Mar 6;95(5):393-399
60 patients undergoing planned one-level posterior lumbar interbody arthrodesis were randomized to study the analgesic effectiveness of a single epidural injection of ropivacaine. Patients received either a 10-mL epidural injection of 0.1% ropivacaine 20 minutes before the skin incision or a control epidural injection of 10 mL of 0.9% saline solution. Outcomes were assessed of the first 48 hours postoperatively and at discharge. Ropivacaine injection provided better early postoperative analgesia and decreased fentanyl consumption within 12 hours, without related complications such as transient motor weakness.
Unlock the full article
Get unlimited access to OrthoEvidence with a free trial
Start TrialCritical appraisals of the latest, high-impact randomized controlled trials and systematic reviews in orthopaedics
Access to OrthoEvidence podcast content, including collaborations with the Journal of Bone and Joint Surgery, interviews with internationally recognized surgeons, and roundtable discussions on orthopaedic news and topics
Subscription to The Pulse, a twice-weekly evidence-based newsletter designed to help you make better clinical decisions
Exclusive access to original content articles, including in-house systematic reviews, and articles on health research methods and hot orthopaedic topics
Or continue reading this full article
Register Now

Subscribe to "The Pulse"
Evidence-Based Orthopaedics direct to your inbox.